To summarize, these studies revealed that higher expression levels of SAPCD2 in tumor specimens were correlated with poorer patient survival 29, 33, and that elevated SAPCD2 expression levels were positively correlated with a number of prognostic markers, including higher tumor stage, higher tumor size, higher histological degree of malignancy, worse tumor differentiation, and metastasis 24, 25, 29, 33. The gene discussed is SAPCD2; the disease is neoplasm.